Medical Oncology

Papers
(The H4-Index of Medical Oncology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer48
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer30
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients27
The immunomodulatory effects of Candida albicans isolated from the normal gastrointestinal microbiome of the elderly on colorectal cancer27
The role of inflammatory indices in the outcome of COVID-19 cancer patients26
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China22
Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis21
Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy20
Notch signaling in oral pre-cancer and oral cancer19
DNMT1 and miRNAs: possible epigenetics footprints in electromagnetic fields utilization in oncology19
Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells19
The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer18
The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 si17
Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice15
Innovation in cancer therapeutics and regulatory perspectives15
sABLATE: a simplified ABLATE score for prediction of complications and outcome in percutaneous thermal ablation of renal lesions15
Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer15
0.14295697212219